Trial Profile

Proof-of-concept endoscopic study of naproxen (OXP 005)

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 10 Mar 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Naproxen (Primary)
Indications Musculoskeletal pain
Focus Adverse reactions; Proof of concept
Sponsors Oxford Pharmascience

Most Recent Events

10 Mar 2015 Title is not official; phase assumed; don't know if patients or volunteers.
10 Mar 2015 New trial record
05 Mar 2015 This study will be initiated after headline results have been reported from the phase I study (trial profile 700253545), according to an Oxford Pharmascience media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com